research reports and media, page-2027

cheers Torpy, Mozz, couldn't find my last macula post to add to but thought I'd follow up on the maculopathy mention associated with Elmiron anyway, I know it was not an issue comparing the risk factors for it with our dose levels however it might eventually do something to the retina if the bioavailability ratios follow through to deposition in tissues? no evidence to support this but playing the devils advocate ...... if we take a 5x ratio then theoretically if you take IPPS for the full course twice a year for 25 years you would reach the minimum level for maculopathy measurement?

Just saying eventually if you do a 5x multiplier it becomes possible eventually - not probable but possible. Most customers I figure will have a full course once a year for 20 years max = zip chance.

Of course nothing in our trials will show anything - too little dose for too short a period, Most of us will be in a nursing home drooling before the maculopathy lawsuit starts.....non plural